Captrust Financial Advisors Grows Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Captrust Financial Advisors raised its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 11.1% during the third quarter, Holdings Channel reports. The firm owned 53,326 shares of the real estate investment trust’s stock after buying an additional 5,324 shares during the quarter. Captrust Financial Advisors’ holdings in Omega Healthcare Investors were worth $2,170,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Allworth Financial LP boosted its holdings in Omega Healthcare Investors by 12.0% in the third quarter. Allworth Financial LP now owns 2,276 shares of the real estate investment trust’s stock valued at $93,000 after purchasing an additional 244 shares during the period. Venturi Wealth Management LLC raised its holdings in shares of Omega Healthcare Investors by 29.4% in the third quarter. Venturi Wealth Management LLC now owns 1,259 shares of the real estate investment trust’s stock valued at $51,000 after buying an additional 286 shares during the last quarter. Cutter & CO Brokerage Inc. boosted its stake in shares of Omega Healthcare Investors by 3.7% during the second quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust’s stock worth $281,000 after buying an additional 290 shares during the period. NCP Inc. grew its holdings in shares of Omega Healthcare Investors by 10.3% during the second quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock worth $113,000 after buying an additional 310 shares during the last quarter. Finally, V Square Quantitative Management LLC lifted its position in Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after acquiring an additional 323 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Down 0.0 %

NYSE:OHI opened at $39.43 on Friday. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The stock has a fifty day simple moving average of $40.50 and a 200-day simple moving average of $37.55. The company has a market capitalization of $10.64 billion, a PE ratio of 28.99, a price-to-earnings-growth ratio of 1.23 and a beta of 0.98.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.80%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s payout ratio is 197.06%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on OHI. Scotiabank raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Royal Bank of Canada raised their price objective on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday, November 11th. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Truist Financial raised their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Finally, Berenberg Bank initiated coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They issued a “buy” rating and a $45.00 price target on the stock. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $40.18.

Insider Activity

In other news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 10.96 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.